BMY

Bristol-Myers Squibb Co

Price:

53.76

USD

Volume:

22,182,408.00

United States | Pharmaceuticals

-130.01 %

Upside

As of 2024-10-03, the Fair Value of Bristol-Myers Squibb Co (BMY) is -16.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 53.76 USD, the upside of Bristol-Myers Squibb Co is -130.01%.

Note: valuation result may not be accurate due to the company's negative EPS.

53.76 USD

Stock Price

-16.13 USD

Fair Price

Peter Lynch's formula is:

Bmy Fair Value

= Earnings Growth Rate x TTM EPS
Bmy Fair Value

= 5.00 x -3.23
Bmy Fair Value

= -16.13
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |

Net income | 3,439.00 | -9,015.00 | 6,994.00 | 6,327.00 | 8,025.00 | 3,154.00 |

YoY growth | -30.10% | -362.14% | 177.58% | -9.54% | 26.84% | -39.47% |

Market Cap (mil) | 108,993.02 |

P/E | |

Forward P/E | 14.72x |

EPS | -3.23 |

Avg earnings growth rate | -39.47% |

TTM earnings | -6,541.00 |